Cytokinetics
CYTK
#2365
Rank
NZ$12.69 B
Marketcap
NZ$103.10
Share price
-1.53%
Change (1 day)
27.20%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -NZ$1.3 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are NZ$87.21 Million. In 2024 the company made an earning of -NZ$1.02 Billion a decrease over its 2023 earnings that were of -NZ$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$1.3 Billion28.31%
2024 -NZ$1.02 Billion12.03%
2023 -NZ$0.91 Billion35.3%
2022 -NZ$0.67 Billion80.65%
2021 -NZ$0.37 Billion69.15%
2020 -NZ$0.22 Billion4.6%
2019 -NZ$0.21 Billion14.49%
2018 -NZ$0.19 Billion-16.83%
2017 -NZ$0.22 Billion-812.8%
2016 NZ$30.79 M-147.81%
2015 -NZ$64.42 Million156.05%
2014 -NZ$25.16 Million-56.56%
2013 -NZ$57.92 Million-16.48%
2012 -NZ$69.35 Million-15.65%
2011 -NZ$82.22 Million-3.24%
2010 -NZ$84.97 Million-308.68%
2009 NZ$40.71 M-141.87%
2008 -NZ$97.24 Million0.21%
2007 -NZ$97.04 Million-7.91%
2006 -NZ$0.11 Billion37.42%
2005 -NZ$76.68 Million16.13%
2004 -NZ$66.03 Million-19.29%
2003 -NZ$81.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.16 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-NZ$53.35 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.47 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$7.57 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA